<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lang J</submitter><funding>Western Australian State Government, and the MRFF</funding><funding>Murdoch University</funding><funding>Agencia Estatal de Investigación</funding><funding>Department of Jobs, Tourism, Science and Innovation, Government of Western Australia</funding><pagination>421-433</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12003606</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>103(4)</volume><pubmed_abstract>COVID-19 vaccines are crucial in reducing SARS-CoV-2 transmission and severe health outcomes. Despite widespread administration, their long-term systemic effects on human metabolism remain inadequately understood. This longitudinal study aims to evaluate IgG responses, 34 cytokines, 112 lipoproteins, and 21 low-molecular-weight metabolites in 33 individuals receiving two to four COVID-19 vaccine doses. Changes in metabolic profiles for the first 16 days post each dose of vaccine, and up to 480 days post-initial dose, were compared to baseline (before vaccination). Additionally, metabolic profiles of vaccinated participants were compared to a reference cohort of unvaccinated individuals without prior exposure to SARS-CoV-2 infection (controls) and SARS-CoV-2 cases. Positive IgG responses we</pubmed_abstract><journal>Journal of molecular medicine (Berlin, Germany)</journal><pubmed_title>Longitudinal study on immunologic, lipoproteomic, and inflammatory responses indicates the safety of sequential COVID-19 vaccination.</pubmed_title><pmcid>PMC12003606</pmcid><funding_grant_id>PID2021-124171OB-I00</funding_grant_id><funding_grant_id>2014349</funding_grant_id><pubmed_authors>Lang J</pubmed_authors><pubmed_authors>Ryan M</pubmed_authors><pubmed_authors>Nitschke P</pubmed_authors><pubmed_authors>Bernal A</pubmed_authors><pubmed_authors>Bong SH</pubmed_authors><pubmed_authors>Wist J</pubmed_authors><pubmed_authors>Millet O</pubmed_authors><pubmed_authors>Loo RL</pubmed_authors><pubmed_authors>Egan S</pubmed_authors><pubmed_authors>Imrie A</pubmed_authors><pubmed_authors>Masuda R</pubmed_authors><pubmed_authors>Holmes E</pubmed_authors><pubmed_authors>Nicholson J</pubmed_authors><pubmed_authors>Lee AC</pubmed_authors><pubmed_authors>Hall D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Longitudinal study on immunologic, lipoproteomic, and inflammatory responses indicates the safety of sequential COVID-19 vaccination.</name><description>COVID-19 vaccines are crucial in reducing SARS-CoV-2 transmission and severe health outcomes. Despite widespread administration, their long-term systemic effects on human metabolism remain inadequately understood. This longitudinal study aims to evaluate IgG responses, 34 cytokines, 112 lipoproteins, and 21 low-molecular-weight metabolites in 33 individuals receiving two to four COVID-19 vaccine doses. Changes in metabolic profiles for the first 16 days post each dose of vaccine, and up to 480 days post-initial dose, were compared to baseline (before vaccination). Additionally, metabolic profiles of vaccinated participants were compared to a reference cohort of unvaccinated individuals without prior exposure to SARS-CoV-2 infection (controls) and SARS-CoV-2 cases. Positive IgG responses we</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Apr</publication><modification>2025-07-03T03:04:42.899Z</modification><creation>2025-07-03T03:04:42.899Z</creation></dates><accession>S-EPMC12003606</accession><cross_references><pubmed>40074874</pubmed><doi>10.1007/s00109-025-02527-y</doi></cross_references></HashMap>